Trials / Conditions / Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
3 registered clinical trials studyying Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukem NCT07194980 | Fred Hutchinson Cancer Center | Phase 2 |
| Recruiting | Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minoritie NCT06859008 | City of Hope Medical Center | Phase 1 |
| Active Not Recruiting | Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocyt NCT05479994 | BeiGene | Phase 2 |